Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kymera Therapeutics (KYMR) Interest Coverage Ratio (2019 - 2025)

Kymera Therapeutics (KYMR) has disclosed Interest Coverage Ratio for 7 consecutive years, with 1087.73 as the latest value for Q4 2025.

  • Quarterly Interest Coverage Ratio rose 20.53% to 1087.73 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 949.46 through Dec 2025, up 9.64% year-over-year, with the annual reading at 944.32 for FY2025, 10.13% up from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 1087.73 at Kymera Therapeutics, down from 944.09 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 371.38 in Q4 2023, with the low at 1402.66 in Q3 2023.
  • Average Interest Coverage Ratio over 5 years is 894.97, with a median of 892.01 recorded in 2021.
  • The sharpest move saw Interest Coverage Ratio surged 43.28% in 2023, then crashed 268.55% in 2024.
  • Over 5 years, Interest Coverage Ratio stood at 666.55 in 2021, then rose by 1.77% to 654.75 in 2022, then soared by 43.28% to 371.38 in 2023, then plummeted by 268.55% to 1368.73 in 2024, then grew by 20.53% to 1087.73 in 2025.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 1087.73, 944.09, and 782.94 for Q4 2025, Q3 2025, and Q2 2025 respectively.